How brain signals called peptides affect the cerebellum
Peptidergic Neuromodulation of the Cerebellum
This research explores how a brain chemical called oxytocin influences the cerebellum, a part of the brain important for movement and social behaviors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11133046 on NIH RePORTER |
What this research studies
Our brains use special chemical messengers, like oxytocin, to help different parts communicate and adapt to various situations. This project aims to understand how these messengers, specifically oxytocin, affect the cerebellum, a brain region that helps fine-tune our movements and social interactions. We are looking at the tiny cells and connections within the cerebellum to see how oxytocin changes their activity. By understanding these basic mechanisms, we hope to learn more about how the brain controls complex behaviors.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients, but future studies building on this knowledge might seek individuals with behavior disorders related to motor control or social interactions.
Not a fit: Patients seeking immediate treatment or direct clinical intervention would not find direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could provide new insights into how brain chemicals influence behavior, potentially leading to better ways to understand and help people with certain behavior disorders.
How similar studies have performed: While the role of neuromodulation in the brain is well-established, the specific mechanisms of peptidergic neuromodulation in the cerebellum, particularly involving oxytocin, are less understood and represent a novel area of focus.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Rudolph, Stephanie — Albert Einstein College of Medicine
- Study coordinator: Rudolph, Stephanie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.